Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Molecular Carcinogenesis|April 7, 2020
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of responseMichal J Besser, Orit Itzhaki, Guy Ben-Betzalel, et al.
Blood Advances|January 4, 2018
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxisFrancesca Lorentino, Myriam Labopin, Katharina Fleischhauer, et al.
Leukemia|November 1, 2024
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemiaAvichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining StudyRoni Shouval, Myriam Labopin, Ori Bondi, et al.
Haematologica|May 13, 2014
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Norbert-Claude Gorin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Blood|February 26, 2004
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantationNicolaus Kröger, Georgia Schilling, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Jose A Perez-Simon, Han Myint, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Transplantation and Cellular Therapy|October 27, 2023
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell TherapyEsther Bachar-Lustig, Assaf Lask, Yaki Eidelstein, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Molecular Carcinogenesis|April 7, 2020
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of responseMichal J Besser, Orit Itzhaki, Guy Ben-Betzalel, et al.
Blood Advances|January 4, 2018
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxisFrancesca Lorentino, Myriam Labopin, Katharina Fleischhauer, et al.
Leukemia|November 1, 2024
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemiaAvichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining StudyRoni Shouval, Myriam Labopin, Ori Bondi, et al.
Haematologica|May 13, 2014
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Norbert-Claude Gorin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Blood|February 26, 2004
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantationNicolaus Kröger, Georgia Schilling, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Jose A Perez-Simon, Han Myint, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Transplantation and Cellular Therapy|October 27, 2023
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell TherapyEsther Bachar-Lustig, Assaf Lask, Yaki Eidelstein, et al.
Pageof 17